MENU
+Compare
THRD
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$3.47
Change
-$0.11 (-3.07%)
Capitalization
156.58M

THRD Third Harmonic Bio Forecast, Technical & Fundamental Analysis

Industry Biotechnology
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for THRD with price predictions
Feb 18, 2025

THRD in -32.99% downward trend, declining for three consecutive days on February 11, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where THRD declined for three days, in of 117 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for THRD entered a downward trend on February 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Moving Average Convergence Divergence (MACD) for THRD just turned positive on February 03, 2025. Looking at past instances where THRD's MACD turned positive, the stock continued to rise in of 19 cases over the following month. The odds of a continued upward trend are .

THRD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.531) is normal, around the industry mean (12.604). P/E Ratio (0.000) is within average values for comparable stocks, (85.387). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.581). THRD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (252.111).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. THRD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. THRD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

THRD is expected to report earnings to rise 7.58% to -35 cents per share on March 26

Third Harmonic Bio THRD Stock Earnings Reports
Q4'24
Est.
$-0.35
Q3'24
Missed
by $0.03
Q2'24
Missed
by $0.01
Q1'24
Beat
by $0.11
Q4'23
Beat
by $0.14
The last earnings report on November 07 showed earnings per share of -33 cents, missing the estimate of -29 cents. With 513.48K shares outstanding, the current market capitalization sits at 156.58M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1700 Montgomery Street
Phone
+1 209 727-2457
Employees
30
Web
https://www.thirdharmonicbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

THRD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, THRD has been loosely correlated with INZY. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if THRD jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THRD
1D Price
Change %
THRD100%
-3.06%
INZY - THRD
45%
Loosely correlated
-3.65%
PRME - THRD
39%
Loosely correlated
+5.28%
ACLX - THRD
38%
Loosely correlated
-1.49%
TRDA - THRD
37%
Loosely correlated
-2.60%
NTLA - THRD
36%
Loosely correlated
+7.76%
More